Try our Advanced Search for more refined results
Securities and Exchange Commission v. Curative Biosciences, Inc. et al
Case Number:
8:18-cv-00925
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
March 12, 2020
Jury Finds CBD Co. Liable In SEC's $4M Illicit Stock Sale Suit
A California federal jury sided with the U.S. Securities and Exchange Commission in its suit accusing a hemp company and its executives of pocketing $4 million in proceeds from the unregistered sale of more than 33 million shares of the company's stock, the SEC announced Thursday.
-
December 19, 2019
CBD Co.'s Atty Sanctioned In SEC Illicit Stock Sale Suit
A California federal judge has sanctioned a lawyer for a hemp company that's facing a U.S. Securities and Exchange Commission lawsuit, saying the company had repeatedly made unfounded arguments through its lawyer that the court already dismissed as frivolous.
-
June 12, 2018
Consultant In SEC's Illicit Stock Sale Suit Nabs Early Deal
A media advertising consultant in California will disgorge several thousand dollars to shake the U.S. Securities and Exchange Commission's suit alleging he funneled proceeds from the sale of unregistered securities to insiders at a company that manufactures hemp health products, according to a consent judgment filed Tuesday in federal court.
-
May 31, 2018
SEC Sues Hemp Health Products Co. Over Illicit Stock Sales
The U.S. Securities and Exchange Commission filed suit Wednesday against a company that manufactures hemp health products, telling a California federal court that a pair of executives concealed the unregistered sale of more than 29 million shares and pocketed a majority of the proceeds.